Investment
Features
FeesSafety
Academy
More
Pluang+

Lazard Global Total Return and Income Fund declares $0.1534 monthly distribution payable October 22, 2026.

Company Fundamentals
22 Sep 2026
PRNewsWire
View Source
Neutral
Lazard Global Total Return and Income Fund declares $0.1534 monthly distribution payable October 22, 2026.

Lazard Global Total Return and Income Fund announced a monthly distribution of $0.15340 per share, payable on October 22, 2026, to shareholders of record as of October 13, 2026. The distribution includes net investment income, capital gains, and a significant portion as return of capital, which means part of the payout may be a return of the investor's original investment rather than earnings. The Fund's five-year average annual return is 5.76%, with an annualized distribution rate of 9.92% based on net asset value as of August 31, 2026. Investors are advised that distributions do not necessarily reflect the Fund's investment performance and should review tax reporting details when available.

Lazard Global Total Return and Income Fund declared a monthly distribution of $0.15340 per share, payable October 22, 2026. For readers following Financials, here is Pluang's market snapshot as of Sep 23, 2026 03:01 WIB: Among 83 priced US Financials stocks, 49 rose and 34 fell. AVAT rose 19.52% to USD 2.23, SCHW fell 5.86% to USD 100.62, and WFC fell 3.69% to USD 83.35. Typical hold times on Pluang range from 11 to 87 days, with order activity favoring buys for SCHW and WFC.

More News

BMO Capital rates Tenet Healthcare 'Market Perform' with 24% EPS growth forecast

BMO Capital rates Tenet Healthcare 'Market Perform' with 24% EPS growth forecast

BMO Capital initiated coverage on Tenet Healthcare with a 'Market Perform' rating, indicating the stock is expected to perform in line with the broader market. The company is forecasted to report a 24.05% increase in Earnings Per Share (EPS) to $4.59...

Analyst Insights
Neutral
2 hours ago
Stocks JAGX, GRML, and VKTX soar on FDA approvals, biotech data, and mineral interest.

Stocks JAGX, GRML, and VKTX soar on FDA approvals, biotech data, and mineral interest.

Jaguar Health (JAGX) surged over 1,150% after the FDA granted fee waivers for its drugs Mytesi and Canalevia-CA1, signaling regulatory support. Greenland Mines (GRML) rose nearly 50% amid growing investor interest linked to U.S.-Greenland security de...

Market News
Bullish
2 hours ago
Market downturn hits top stocks: New Fortress Energy falls nearly 25%, quantum and tech stocks also slide.

Market downturn hits top stocks: New Fortress Energy falls nearly 25%, quantum and tech stocks also slide.

The market experienced a downturn with significant losses among key stocks. New Fortress Energy dropped 24.7% amid ongoing volatility in energy sectors, while Xanadu Quantum Technologies fell 21.7% reflecting sensitivity in quantum stocks to commerci...

Market News
Bearish
2 hours ago
Capri Holdings rated Hold amid takeover uncertainty but expects growth from new products and marketing.

Capri Holdings rated Hold amid takeover uncertainty but expects growth from new products and marketing.

Jefferies maintains a Hold rating on Capri Holdings due to uncertainty over a potential takeover. Despite a flat global luxury market, Capri's management expects growth in the second half of 2026, driven by new product launches, increased marketing, ...

Analyst Insights
Neutral
3 hours ago
Avalanche jumps 55% as Bitwise launches first staking-enabled AVAX ETF with 5.4% yield target

Avalanche jumps 55% as Bitwise launches first staking-enabled AVAX ETF with 5.4% yield target

Avalanche (AVAX) surged 55% in a week following the launch of Bitwise's Avalanche ETF (BAVA), the first regulated fund offering direct exposure to AVAX tokens with an active staking model. The ETF stakes about 70% of its holdings to generate an estim...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App